Gaddiel Rodriguez

Patent Law Clerk

Overview

Dr. Gaddiel Rodriguez is a patent agent with Foley & Lardner LLP, based in the firm’s Boston office, where he is a member of the firm’s Chemical, Biotech & Pharmaceutical Practice.

Gaddiel has experience in patent application drafting and prosecution, freedom-to-operate analyses, due-diligence research, and market research. He specializes in biomolecular sciences with extensive experience in pharmacological, biological, and biophysical methods.

Prior to joining Foley, Gaddiel was a patent agent for an international law firm, where his practice focused on worldwide life sciences patent portfolio development, patent drafting and prosecution, IP due diligence, FTO/patentability analysis, and support for litigation/PTAB proceedings.

Gaddiel earned his Ph.D. in molecular biophysics at The Johns Hopkins University School of Medicine, where he studied mechanisms of protein-nucleic acid interactions in DNA repair.  Gaddiel earned his undergraduate degree in Biochemistry from Hunter College, where he studied the effects of single nucleotide polymorphisms in beta thalassemia and sickle cell disease.

Gaddiel is pursuing his Juris Doctor degree at The UNH Franklin Pierce School of Law, with an anticipated graduation date of 2025.

Education

  • The Johns Hopkins University School of Medicine, Baltimore, MD (Ph.D., 2019)
    • Molecular Biophysics
  • Hunter College, New York City, NY (B.A, 2014)
    • Chemistry/Biochemistry

Recognition

  • Research Supplement to Promote Diversity in Health-Related Research – US NIH/NIGMS
  • Minority Access to Research Careers (MARC) – US NIH/NIGMS

Publications

  • Rodriguez G, et al. “Disordered N-Terminal Domain of Human Uracil DNA Glycosylase (hUNG2) Enhances DNA Translocation.” ACS Chem Biol, 12, (2017): 2260-2263
  • Coauthor, “Measurement of Nanoscale DNA Translocation by Uracil DNA Glycosylase in Human Cells.,” Nucleic Acids Res, 45, 12413(2017)
  • Coauthor, “AP-Endonuclease 1 Accelerates Turnover of Human 8-Oxoguanine DNA Glycosylase by Preventing Retrograde Binding to the Abasic-Site Product.” Biochemistry, 56, 1974 (2017)
  • Coauthor, “N-terminal Domain of Human Uracil DNA Glycosylase (hUNG2) Promotes Targeting to Uracil Sites Adjacent to ssDNA-dsDNA Junctions.” Nucleic Acids Res, 46, 7169 (2018)
  • Rodriguez G, et al. “Macromolecular crowding induces compaction and DNA binding in the disordered N-terminal domain of hUNG2.” DNA repair, 86, (2020): 102764

Admissions

  • United States Patent and Trademark Office

 

Capabilities